What
is Asthma?
Asthma
is a serious lung disease that causes reversible narrowing of the bronchial
tubes that carry air into the lungs. This causes problems getting air
into and out of the lungs.

The bronchial
airways of asthmatics react to things like smoke, dust, molds, pollen,
dander and many other things which do not affect persons without asthma.
During
early stages of an asthma attack stimulation of cells within bronchial
airways trigger release of substances (e.g., histamine, tryptase, leukotrienes
and prostaglandins) called inflammatory mediators. These mediators cause
smooth muscle within the walls of the bronchial airways to contract,
resulting in narrowing of the airways.
Inflammatory
mediators also cause certain cells (eosinophils and neutrophils) to
become activated and migrate to the bronchial airways where they cause
injury. This "late phase asthmatic response" causes inflammation
of surrounding bronchial tissues and excessive secretion of mucous into
the bronchial airways. This causes even further narrowing of the airways.
Unlike early phase asthma, late phase airway swelling is not quickly
reversible.

It is very
important to understand that asthma is a chronic disease for many affected
persons due to persistent inflammation and swelling in the bronchial
tubes, even when a person does not seem to have asthma symptoms.
Facts
about Asthma
If you
have asthma, you are not alone. More than 17 million people in the United
States have this lung disease. Of these, almost 5 million are children.
1
Asthma
is responsible for more than 14 million visits a year to a health care
professional, almost a half-million hospitalizations, 1 million emergency
room visits, and more than 5,000 deaths annually in the United States.
Proper
asthma care could prevent a vast majority of these problems. But you
do not have to put up with the problems asthma can cause. Your Asthma
Can Be Controlled With Proper Care With your doctos help, you can control
your asthma and become free of symptoms.
What
causes Asthma?
The cause
of asthma is not known. Many different factors play a role in the development
of asthma in different individuals with the end result being the reversible
narrowing of bronchial airways. 2 Asthma
triggers include:
- Immunologic
factors
- Viral
respiratory infections (particularly in children under 2)
- Sinus
infections
- Allergies
(most important trigger in children over 2 years of age)
- Exercise-
induced asthma (EIA)
- Irritants
such as cigarette smoke, burning wood, and air pollution
- Gastroesophageal
reflux disease
- Medications
- Food
additives and sulfites
- Weather
- Psychologic
stressors
- Occupational
asthma
Who
gets Asthma?
Asthma
is a problem among all races. But the asthma death rate and hospitalization
rate for blacks are three times the rate of whites. Although asthma
is more common in children and young adults it can occur at any age.
Asthma occurring in children over 2 years of age has identifiable allergic
triggers 90% of the time. Asthma occurring for the first time in adults
often has less identifiable triggers and tends to be more resistant
to treatment.
What
are symptoms of Asthma?
Asthma
symptoms can range from very mild to severe, depending on both the individual
and the particular situation.
Common
Symptoms of Asthma include:
- Coughing
- Wheezing
(a whistling noise when you breathe)
- Chest
tightness (the feeling that someone is squeezing or sitting on your
chest)
- Shortness
of breath
You may
have all of these symptoms, some of them, or just one. Symptoms can
be mild or severe. 3
Asthma
should be considered in persons with persistent cough (particularly
if the cough is worse at night) or if the symptoms worsen with exercise,
viral illness, weather changes or exposures to airborne chemicals, dust,
tobacco smoke or other allergens, such as animal dander, cockroaches,
house dust mites, mold and pollens.
How
is Asthma treated and prevented?
Successful
treatment and prevention of asthma involves being thoroughly educated
about asthma, working closely with your doctor, recognizing and avoiding
known triggers, and proper use of medications.
Know
how well your lungs are working
Two tests
of how well your lungs work are spirometry and peak expiratory flow
(PEF) measurements.
Spirometry
measures how much air you blow out in one second- This number is know
as the forced expiratory volume (FEV 1). Spirometry requires a sophisticated
device that is usually only available in a physician's office or hospital.
Spirometry devices can also calculate other values that help distinguish
asthma from other breathing problems.
Spirometry
is recommended:
- At initial
assessment/diagnosis of asthma
- After
treatment started and PEF has stabilized
- Every
1 to 2 years
Peak
flow (PEF) measures the maximum speed you blow out air. These
results are not as accurate but are simple to perform. A peak flow
meter can be used any place and is very inexpensive. Peak flow meters
are for monitoring of already diagnosed asthma, not diagnosis.
PEF monitoring:
- All
patients except those with MILD-INTERMITTENT asthma should:
- Learn
to monitor their PEF and have a peak flow meter at home
- Monitor
during asthma flare-ups
- Perform
daily monitoring for better control (MODERATE or SEVERE)
All
asthma patients should know their expected best peak flow and use it
to compare future peak flow measurements. Symptoms of asthma are often
not noticeable until PEF has dropped below 80% of predicted best measurement.

| Derived
from Asthma 2000 Monograph Series, Asthma Management: Current Clinical
Practice; R.A. Nathan M.D. and S.L. Spector M.D. Eds. PP 7, 1999. |
Know
how to correctly use your medications
Asthma medications
generally come in inhaled or oral forms. Most treatment consists of using
inhaled medications. Medications are most effective and have the least
effects on other parts of the body when inhaled directly into the lungs.
Medications can be inhaled using :
Metered
dose inhaler (MDI)
An MDI
(or puffer) is a small canister containing asthma medication that delivers
the same amount of medication each time you spray it in your mouth.
MDI's are reliable and can be carried anyplace. They may be hard for
young children and those with coordination impairments to use.

| Derived
from Asthma 2000 Monograph Series, Asthma Management: Current Clinical
Practice; R.A. Nathan M.D. and S.L. Spector M.D. Eds. PP 7, 1999. |
Medication
nebulizer
A nebulizer
is a small machine turns liquid (nebulizable) forms of asthma medication
into fine mist that you inhale. Anyone can use nebulizers and the amount
of medication used can be adjusted. Nebulizers need a power source,
require more maintenance and are not needed by most asthmatics.
The best
treatment is prevention of asthma attacks- This means keeping on top
of your asthma when you are feeling well and always being prepared in
case of emergency!
Asthma
Medications
Asthma medications
work in one of two basic ways:
- Bronchodilators
relax the tightening of muscles that narrow the bronchial airways: They
have little or no effect on the inflammatory (swelling) part of an asthma
attack. Bronchodilators
are typically used to give quick relief when a person starts to develop
symptoms of an asthma attack.
- Inflammatory
mediators are medications that either help prevent or treat the
inflammatory phase of asthma: These medications have much less effect
on treating spasm of bronchial muscles. Anti-inflammatory medications
are used on a regular basis ( except in persons with very mild or infrequent
asthma attacks) for long term control to prevent recurrent asthma attacks.
It is important
to remember that many asthmatics will need to take at least two different
types of medications.
| Bronchodilators
|
| Beta
agonists |
Relax bronchial smooth muscle
Most effective when inhaled
May also increase heart rate and cause muscle tremor
(much less so with newer beta agonists). Safe to use
Both
short and long acting beta agonists available. Only short acting
medications should be used to treat worsening asthma symptoms.
Long acting beta agonists should not be used as a single agent
for long-term control but instead should be used in combination
with inhaled corticosteroids or other anti-inflammatory agents.
Salmeterol is useful in the management of nocturnal and exercise-induced
asthma.
|
| Anticholinergics |
Relax
bronchial smooth muscle by different mechanism than beta agonists
Most effective when inhaled
May have additive benefits when used in combination
with beta agonist.
Ipratropium
(atrovent) safe to use with relatively few side effects. Atropine
(not commonly used for asthma) may produce increased heart rate,
restlessness, thirst, blurry vision, trouble urinating, or increased
eye pressure.
|
| Theophylline |
Is a central nervous system stimulant as well as bronchodilator
Older medication taken orally.
Not as commonly used because less effective and more
side effects than beta agonists and anticholinergics.
Blood levels must be checked over time.
Theophylline
still used in mild asthma, in sustained release form for control
of night symptoms and in some elderly persons with combination
of asthma and emphysema.
|
| Anti-inflammatory
Medications |
| Corticosteroids |
Most potent medications available to decrease swelling of
the bronchial airways.
Not the same thing as muscle building steroids.
May be inhaled or taken orally.
Inhaled steroids are used to prevent symptoms and
control mild, moderate, and severe asthma. Inhaled steroids are
safe when taken at recommended doses. This is because the medicine
goes right to your lungs where you need it. This reduces the amount
of medicine you need and the chance of any side effects.
Reduced growth rate may occur in children
on long term systemic (oral or injected) corticosteroids. Growth
suppression has not been clearly shown with inhaled medications.
Steroid tablets or liquids are used safely for short times
to quickly bring asthma under control. They are also used longer
term to control the most severe asthma.
|
| Mast-Cell
Stabilizers |
Help prevent both early and late phase bronchoconstriction
by preventing the release of inflammatory mediators from sensitized
mast cells in bronchial tissues. Not a true anti-inflammatory
medication.
Extremely safe with no serious side effects and
no known interactions with other medications.
Medications of choice in children for long term
control of asthma but less effective than corticosteroids.
Quite effective for allergic type asthma.
May leave bad taste in mouth
|
| Leukotriene
Modifiers |
Medications in this group either block or inhibit the formation
of leukotrienes (molecules made by a number of different cells
that cause inflammation).
Have anti-inflammatory effect.
Work sooner than inhaled steroids
Can be given by mouth once or twice daily
Relatively safe although inflammation of liver can
occur in rare cases.
Not as effective as inhaled corticosteroids
May decrease the amount of corticosteroids required
No agent approved for use in children under 6 years
|
|
Asthma
Long-Term-Control Medications- Generic name | Brand name
|
| Steroids: |
Inhaled
beclomethasone
Double Strength budesonide
flunisolide
fluticasone
triamcinolone |
Beclovent ¨ Vanceril ¨ , Vanceril ¨
Pulmicort Turbuhaler ¨
AeroBid ¨ , AeroBid-M ¨
Flovent ¨
Azmacort ¨ |
| Mast
Cell Stabilizers |
Inhaled
cromolyn sodium
Inhaled nedocromil sodium |
Intal
¨
Tilade ¨ |
|
Nedocromil appears to be more effective than cromolyn in inhibiting
bronchospasm induced by exercise, cold air and provocative testing. |
| Leukotriene
Modifiers [Tablets] |
zafirlukast
zileuton
montelukast
|
Accolate
¨
Zyflo ¨
Singulair |
| Long-Acting
Beta 2 -Agonists |
levalbuterol
HCl
salmeterol (inhaled)
albuterol (tablets) |
Xopenex
(Inhalation Solution)
Serevent ¨
Volmax ¨, Proventil Repetabs ¨ (extended release) |
| Theophylline:
Tablets or liquid |
Aerolate
¨ III Aerolate ¨ JR Aerolate ¨ SR
Choledyl ¨ SA
Elixophyllin ¨
Quibron ¨ -T Quibron ¨ -T/SR
Slo-bid ¨ Slo-Phyllin ¨
Theo-24 ¨ Theochron ¨ Theo-Dur ¨ Theolair ¨ Theolair ¨ -SR
T-Phyl ¨ Uni-Dur ¨ Uniphyl ¨
|
| Asthma
Quick-Relief Medications - Generic name | Brand name |
| Short-Acting
Beta 2 -Agonists |
| Inhaled
albuterol |
Airet
¨ Proventil ¨ Proventil HFA ¨ Ventolin ¨ Ventolin ¨ Rotacaps |
bitolterol
pirbuterol
terbutaline |
Tornalate
¨
Maxair ¨
Brethaire ¨; Brethine ¨ & Bricanyl ¨ (tablets only) |
| Anticholinergics |
| Inhaled
ipratropium bromide |
Atrovent
¨ |
| Steroids:
Tablets or liquids |
| methylprednisolone |
Medrol
¨ |
| prednisone |
Prednisone
Deltasone ¨ Orasone ¨ Liquid Pred ¨ Prednisone Intensol ¨ |
| prednisolone |
Prelone
¨ Pediapred ¨ |
| Partly
derived from: U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public
Health Service National Institutes of Health National Heart, Lung,
and Blood Institute NIH Publication No. 97-2339 Originally printed
1990 Revised September 1997 |
Immunotherapy
Immunotherapy
consists of determining what substances a person is allergic to and desensitizing
them to the allergen by administering periodic shots of the allergen.
According
to the American Academy of Allergy and Immunology, approximately 33 million
injections are given per year in the United States. Immunotherapy appears
to be effective for the treatment of allergic rhinoconjunctivitis (runny
nose and watery eyes due to allergy) and for insect sting allergies.
Is not
routinely recommended (nor proven effective) for treatment of asthma,
particularly severe asthma. There is healthy debate on the effectiveness
of Immunotherapy in the treatment of asthma, with opinions varying from
"effective" to "completely ineffective." However, some authorities argue
that the risks of Immunotherapy exceed the benefits in patients with unstable
asthma.
Classification
of Asthma
An expert
panel for the National Asthma Education and Prevention Program (NAEPP)
recently issued new guidelines that recommend the use of a revised classification
system for asthma. Based on these guidelines, asthma is classified as
mild intermittent, mild persistent, moderate persistent and severe persistent.
It is important to note that patients at any level of severity may have
severe, lifethreatening exacerbations.
Low grade
(not obviously noticeable) progressive inflammation occurs in the bronchial
tubes of asthmatics not optimally treated. This means that when asthma
symptoms occur there is much less room for safety because the bronchial
airways are already narrowed.
| Asthma
Severity |
Treatment
Recommendations |
| MILD
INTERMITTENT ASTHMA |
STEP
1 |
- Symptoms
< 2 times per week
- No
symptoms between flares
- Flares
brief
- Normal
peak flow between flares
- Night
symptom< 2 times per month
- Lung
tests > 80% predicted*
- Lung
test variability < 20%
* Peak
flow or FEV1
|
- Short
acting beta-agonist as needed
(daily medication not needed)
|
| MILD-PERSISTENT
ASTHMA |
STEP
2 |
- Symptoms
> twice a week but < 1 time a day
- flares
affect activity
- Night
symptoms > twice per month
- Lung
tests ³ 80% predicted*
- Lung
test variability 20 - 30 %
|
- Daily
anti-inflammatory medication
(low- dose inhaled corticosteroids, mast cell stabilizers, leukotriene
modifiers, or sustained release Theophylline)
- Short
acting ß-agonist as needed
|
| MODERATE-PERSISTENT
ASTHMA |
STEP
3 |
- Daily
symptoms
- Daily
use of inhaled ß-agonist
- Flares
affect activity > 2 times per week and may last days
- Night
symptoms > 1 time per week
- FEV1
or peak flow > 60% but < 80% of predicted (when not having
flare)
- Peak
flow variability > 30%
|
|
| SEVERE-PERSISTENT
ASTHMA |
STEP
4 |
- Continual
symptoms
- Limited
physical activity
- Frequent
flares
- FEV
1 < 60% predicted
- Peak
flow variability > 30%
|
- Daily
anti-inflammatory medication
- High
dose inhaled corticosteroids
PLUS
- Long-acting
bronchodilator
AND
- Corticosteroid
tablets or syrup
|
|
1997
NAEP guidelines
|
It is very
important to realize that all asthmatics except those with
mild-intermittent asthma need to be taking daily anti-inflammatory medications
even when they do not "feel" asthma symptoms.
How
can I keep my Asthma under control?
Controlling
your asthma requires:
- Understanding
of what asthma is
- Having
a written asthma management plan (keeping a copy of the plan with any
care providers for children)
- Proper
use of medications
- Regular
use of peak flow meters
- Avoidance
of asthma triggers.
Below is
summary of potential triggers and control measures along with a "Traffic
light color scheme" for using peak flow measurements to determine
whether current asthma therapy is working.
|
Environmental Triggers in Asthma and Control Measures |
| |
Potential
triggers
|
Control
measures
|
| House
dust mite |
Cover
pillows, mattresses and box springs with zippered cases.
Wash
all bedding in hot water (54.4°C [130°F]) every
10 to 14 days.
Use
microfilter vacuum bags.
Reduce
humidity levels with air conditioner and/or dehumidifier.
Use
air filtering devices, especially in bedroom and family room.
Remove
bedroom and family room carpeting (small, washable area rugs
are an alternative).
|
| Cockroach
allergen |
Cockroach
extermination, preferably by professional exterminators. |
- Animal
allergens
- Cat
saliva and dander
- Dog
allergens
- Rodent
urine
|
Remove
animal from the home, if possible (cat allergens remain in
the home for up to six months after the animal is removed).
When
removal is not possible, confine the animal to carpet-free
areas outside the bedroom and use a high-efficiency particulate
air filter.
|
- Pollen
allergens
- Trees
- Grasses
- Weeds
|
Remain
indoors as much as possible during times of increased pollen
levels.
Use
home and auto air conditioners (with closed vents) during
allergy season.
|
- Mold
allergens
- Outdoor
or "field" fungi
- Indoor
or "storage" fungi
|
For
outdoor mold, stay indoors and keep windows closed.
For
indoor mold, use dehumidifier in basement and air conditioners,
especially in bedroom and family room.
Maintain
good ventilation in bathroom and kitchen.
|
- Nonallergic
airborne irritants
- Tobacco
smoke
- Smoke
from wood-burning stoves, fireplaces and other sources
- Fumes,
strong odors
|
Avoid
the irritants. |
Derived
from National Asthma Education and Prevention Program (National
Heart, Lung, Blood Institute) Second Expert Panel on the Management
of Asthma. Expert panel report 2: guidelines for the diagnosis
and management of asthma. Bethesda, Md.: National Institutes
of Health, 1997; publication no. 97-4051. |
|

| Derived
from Asthma 2000 Monograph Series, Asthma Management: Current Clinical
Practice; R.A. Nathan M.D. and S.L. Spector M.D. Eds. pp. 4, 1999. |
When
should I call my Doctor?
Call your
doctor or go to an emergency room when:
- Asthma
symptoms to worsen despite following a treatment plan
- When your
peak flow is less than 50% of your best
- If you
must use your bronchodilator more frequently than every 4 hours
- If you
are having mild or moderate symptoms and are out of medication
Use of nonprescription
inhalers, such as primatene, should be avoided. Prescription bronchodilators
are more effective and safer.
Only prescription
medications (corticosteroids) can treat moderate to severe inflammatory
phase of asthma.
When
should I call 911?
Call 911
immediately (not your doctors office) if:
- You are
severely short of breath and do not have a bronchodilator inhaler available
- You are
severely short of breath despite using a bronchodilator inhaler
- You have
a normal (or close to normal) peak flow when well and it is now less
than 200
DO NOT
DRIVE OR HAVE ANYONE ELSE DRIVE YOU! Ambulance crews are equiped to
give high flow breathing treatments and other lifesaving medications.
Where
can I learn more about Asthma?
Contact these
groups to learn more about asthma:
National
Asthma Education and Prevention Program NHLBI Information Center
P.O. Box 30105, Bethesda, MD 20824-0105
301-251-1222
Internet: http://www.nhlbi.nih.gov/health/public/lung/asthma/asth_fs.htm
American
Academy of Allergy, Asthma, and Immunology
800-822-2762
Internet: http://www.aaaai.org
American
College of Allergy, Asthma, and Immunology
800-842-7777
Internet: http://www.acaai.org
American
Lung Association
800-586-4872
Internet: http://www.lungusa.org
Asthma and
Allergy Foundation of America
800-727-8462
Internet: http://www.aafa.org
New Strategies
in the Medical Management of Asthma
KAREN M. GROSS, M.D.,CHARLES D. PONTE, PHARM.D.
from American Family Physician, July 1998
Internet: http://www.aafp.org/afp/980700ap/gross.html
(targeted to healthcare providers)
Citations
- Asthma
2000 Monograph Series, Asthma Management: Current Clinical Practice;
R.A. Nathan M.D. and S.L. Spector M.D. Eds. PP v, 1999.
- Asthma
and Bronchiolitis, S. H. Inkelis in Emergency Medicine- A Comprehensive
Study Guide 4th Ed., Tintinalli, J.E, Ruiz, E. and R. L. Krome eds.,
PP 629-630, 1996.
- Facts
about Asthma
- U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service
National Institutes of Health National Heart, Lung, and Blood Institute
NIH Publication No. 97-2339 Originally printed 1990 Revised September
1997
Top
Doctors
Corner INternet Group, Inc. 1997-2004
This
site uses "Frames". If you do not see a Navigation
Menu at the top of this page please click "Reload"
Button to view entire page.

|
|